Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease

202085 citationsJournal Articlebronze Open Access

Authors

Yves Lacasse · Université Laval

Frédéric Sériès · Université Laval

François Corbeil · Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec

Marc Baltzan · McGill University

Bruno Paradis · Centre Integre de Sante et de Services Sociaux de Laval

Paula Simão · Hospital Pedro Hispano

Araceli Abad Fernández

Abstract

Our underpowered trial provides no indication that nocturnal oxygen has a positive or negative effect on survival or progression to long-term oxygen therapy in patients with COPD. (Funded by the Canadian Institutes of Health Research; INOX ClinicalTrials.gov number, NCT01044628.).

Topics & Keywords

Chronic Obstructive Pulmonary Disease (COPD) Research Respiratory Support and Mechanisms Neonatal Respiratory Health Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 383, Issue 12, pp. 1129-1138

DOI: 10.1056/nejmoa2013219

Field-Weighted Citation Impact: 6.93